Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study
Abstract
Experimental evidence supports a role of lipid dysregulation in ovarian cancer progression. We estimated associations with ovarian cancer risk for circulating levels of four lipid groups, previously hypothesized to be associated with ovarian cancer, measured 3–23 years before diagnosis.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Oct 08, 2019
- Source ID
- 10.1093/jnci/djz195
Entities
People
- A Heather Eliassen
- Clary B Clish
- Julian Avila
- Oana A Zeleznik
- Peter Kraft
- Shelley S. Tworoger
Organizations
- H. Lee Moffitt Cancer Center & Research Institute
- Harvard Medical School
- Harvard University
- National Institutes of Health
- United States Department of Defense